v3.25.2
UNAUDITED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
$ in Thousands
Total
Total Global Payments Shareholders’ Equity
Number of Shares
Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Loss
Nonredeemable Noncontrolling Interests
Total Equity
Balance at beginning of period (in shares) at Dec. 31, 2023     260,383,000          
Balance at beginning of period at Dec. 31, 2023   $ 22,999,210   $ 19,800,953 $ 3,457,182 $ (258,925) $ 280,340 $ 23,279,550
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) $ 712,337 688,067     688,067   20,436 708,503
Other comprehensive income (loss) $ (163,534) (133,362)       (133,362) (22,618) (155,980)
Stock issued under share-based compensation plans (in shares)     1,277,000          
Stock issued under share-based compensation plans   25,137   25,137       25,137
Common stock repurchased - share-based compensation plans (in shares)     (334,000)          
Common stock repurchased - share-based compensation plans   (44,044)   (44,044)       (44,044)
Share-based compensation expense   83,362   83,362       83,362
Repurchase of common stock (in shares) (6,972,979)   (6,973,000)          
Repurchases of common stock $ (909,200) (909,237)   (909,237)       (909,237)
Distributions to noncontrolling interests             (10,881) (10,881)
Contributions from noncontrolling interests             89 89
Reclassification of redeemable noncontrolling interest to nonredeemable noncontrolling interest             358,872 358,872
Purchase of capped calls related to issuance of convertible notes, net of taxes   (194,677)   (194,677)       (194,677)
Cash dividends declared   (127,042)     (127,042)     (127,042)
Balance at end of period (in shares) at Jun. 30, 2024     254,353,000          
Balance at end of period at Jun. 30, 2024   22,387,414   18,761,494 4,018,207 (392,287) 626,238 23,013,652
Beginning balance at Dec. 31, 2023 507,965              
Redeemable Noncontrolling Interests                
Net income 3,834              
Other comprehensive income (7,554)              
Contributions from noncontrolling interests 2,027              
Reclassification of redeemable noncontrolling interest to nonredeemable noncontrolling interest (358,872)              
Ending balance at Jun. 30, 2024 147,400              
Balance at beginning of period (in shares) at Mar. 31, 2024     255,131,000          
Balance at beginning of period at Mar. 31, 2024   22,215,831   18,806,396 3,706,873 (297,438) 627,245 22,843,076
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 389,275 374,760     374,760   12,743 387,503
Other comprehensive income (loss) $ (101,934) (94,849)       (94,849) (7,617) (102,466)
Stock issued under share-based compensation plans (in shares)     145,000          
Stock issued under share-based compensation plans   14,106   14,106       14,106
Common stock repurchased - share-based compensation plans (in shares)     (12,000)          
Common stock repurchased - share-based compensation plans   (1,381)   (1,381)       (1,381)
Share-based compensation expense   43,245   43,245       43,245
Repurchase of common stock (in shares) (910,980)   (911,000)          
Repurchases of common stock $ (100,900) (100,872)   (100,872)       (100,872)
Distributions to noncontrolling interests             (6,133) (6,133)
Cash dividends declared   (63,426)     (63,426)     (63,426)
Balance at end of period (in shares) at Jun. 30, 2024     254,353,000          
Balance at end of period at Jun. 30, 2024   22,387,414   18,761,494 4,018,207 (392,287) 626,238 23,013,652
Beginning balance at Mar. 31, 2024 143,069              
Redeemable Noncontrolling Interests                
Net income 1,772              
Other comprehensive income 532              
Contributions from noncontrolling interests 2,027              
Ending balance at Jun. 30, 2024 147,400              
Balance at beginning of period (in shares) at Dec. 31, 2024     248,709,000          
Balance at beginning of period at Dec. 31, 2024 22,855,944 22,280,686   18,118,942 4,774,736 (612,992) 575,258 22,855,944
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 558,870 547,374     547,374   22,088 569,462
Other comprehensive income (loss) $ 620,252 509,020       509,020 89,432 598,452
Stock issued under share-based compensation plans (in shares)     1,394,000          
Stock issued under share-based compensation plans   16,245   16,245       16,245
Common stock repurchased - share-based compensation plans (in shares)     (365,000)          
Common stock repurchased - share-based compensation plans   (37,902)   (37,902)       (37,902)
Share-based compensation expense   79,550   79,550       79,550
Repurchase of common stock (in shares) (7,261,834)   (7,262,000)          
Repurchases of common stock $ (680,400) (680,397)   (680,397)       (680,397)
Distributions to noncontrolling interests             (30,095) (30,095)
Cash dividends declared   (121,501)     (121,501)     (121,501)
Balance at end of period (in shares) at Jun. 30, 2025     242,476,000          
Balance at end of period at Jun. 30, 2025 23,249,758 22,593,075   17,496,438 5,200,609 (103,972) 656,683 23,249,758
Beginning balance at Dec. 31, 2024 160,623              
Redeemable Noncontrolling Interests                
Net income (10,592)              
Other comprehensive income 21,800              
Ending balance at Jun. 30, 2025 171,831              
Balance at beginning of period (in shares) at Mar. 31, 2025     245,362,000          
Balance at beginning of period at Mar. 31, 2025   22,248,343   17,678,643 5,019,346 (449,646) 609,439 22,857,782
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 246,098 241,640     241,640   13,864 255,504
Other comprehensive income (loss) $ 413,268 345,674       345,674 53,148 398,822
Stock issued under share-based compensation plans (in shares)     164,000          
Stock issued under share-based compensation plans   9,905   9,905       9,905
Common stock repurchased - share-based compensation plans (in shares)     (7,000)          
Common stock repurchased - share-based compensation plans   (560)   (560)       (560)
Share-based compensation expense   39,810   39,810       39,810
Repurchase of common stock (in shares) (3,043,484)   (3,043,000)          
Repurchases of common stock $ (231,400) (231,360)   (231,360)       (231,360)
Distributions to noncontrolling interests             (19,768) (19,768)
Cash dividends declared   (60,377)     (60,377)     (60,377)
Balance at end of period (in shares) at Jun. 30, 2025     242,476,000          
Balance at end of period at Jun. 30, 2025 23,249,758 $ 22,593,075   $ 17,496,438 $ 5,200,609 $ (103,972) $ 656,683 $ 23,249,758
Beginning balance at Mar. 31, 2025 166,791              
Redeemable Noncontrolling Interests                
Net income (9,406)              
Other comprehensive income 14,446              
Ending balance at Jun. 30, 2025 $ 171,831